272 related articles for article (PubMed ID: 15240009)
1. Protein kinase A inhibits lysophosphatidic acid induction of serum response factor via alterations in the actin cytoskeleton.
Nguyen GH; French R; Radhakrishna H
Cell Signal; 2004 Oct; 16(10):1141-51. PubMed ID: 15240009
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase A inhibits lysophosphatidic acid-induced migration of airway smooth muscle cells.
Hirakawa M; Karashima Y; Watanabe M; Kimura C; Ito Y; Oike M
J Pharmacol Exp Ther; 2007 Jun; 321(3):1102-8. PubMed ID: 17347321
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid and endothelin-induced proliferation of ovarian cancer cell lines is mitigated by neutralization of granulin-epithelin precursor (GEP), a prosurvival factor for ovarian cancer.
Kamrava M; Simpkins F; Alejandro E; Michener C; Meltzer E; Kohn EC
Oncogene; 2005 Oct; 24(47):7084-93. PubMed ID: 16044162
[TBL] [Abstract][Full Text] [Related]
4. Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the beta 2-adrenergic receptor.
Rangarajan S; Enserink JM; Kuiperij HB; de Rooij J; Price LS; Schwede F; Bos JL
J Cell Biol; 2003 Feb; 160(4):487-93. PubMed ID: 12578910
[TBL] [Abstract][Full Text] [Related]
5. Regulation of astrocyte morphology by RhoA and lysophosphatidic acid.
Ramakers GJ; Moolenaar WH
Exp Cell Res; 1998 Dec; 245(2):252-62. PubMed ID: 9851865
[TBL] [Abstract][Full Text] [Related]
6. cAMP-induced actin cytoskeleton remodelling inhibits MKL1-dependent expression of the chemotactic and pro-proliferative factor, CCN1.
Duggirala A; Kimura TE; Sala-Newby GB; Johnson JL; Wu YJ; Newby AC; Bond M
J Mol Cell Cardiol; 2015 Feb; 79():157-68. PubMed ID: 25446180
[TBL] [Abstract][Full Text] [Related]
7. cAMP inhibits migration, ruffling and paxillin accumulation in focal adhesions of pancreatic ductal adenocarcinoma cells: effects of PKA and EPAC.
Burdyga A; Conant A; Haynes L; Zhang J; Jalink K; Sutton R; Neoptolemos J; Costello E; Tepikin A
Biochim Biophys Acta; 2013 Dec; 1833(12):2664-2672. PubMed ID: 23797058
[TBL] [Abstract][Full Text] [Related]
8. Regulation of cytoskeleton organization and paxillin dephosphorylation by cAMP. Studies on murine Y1 adrenal cells.
Han JD; Rubin CS
J Biol Chem; 1996 Nov; 271(46):29211-5. PubMed ID: 8910579
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Schwann cell morphology and adhesion by receptor-mediated lysophosphatidic acid signaling.
Weiner JA; Fukushima N; Contos JJ; Scherer SS; Chun J
J Neurosci; 2001 Sep; 21(18):7069-78. PubMed ID: 11549717
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Egr1 expression underlies the anti-mitogenic effects of cAMP in vascular smooth muscle cells.
Kimura TE; Duggirala A; Hindmarch CC; Hewer RC; Cui MZ; Newby AC; Bond M
J Mol Cell Cardiol; 2014 Jul; 72(100):9-19. PubMed ID: 24534707
[TBL] [Abstract][Full Text] [Related]
11. The cross talk between protein kinase A- and RhoA-mediated signaling in cancer cells.
Chen Y; Wang Y; Yu H; Wang F; Xu W
Exp Biol Med (Maywood); 2005 Nov; 230(10):731-41. PubMed ID: 16246900
[TBL] [Abstract][Full Text] [Related]
12. Growth factor-induced transcription via the serum response element is inhibited by cyclic adenosine 3',5'-monophosphate in MCF-7 breast cancer cells.
Lowe WL; Fu R; Banko M
Endocrinology; 1997 Jun; 138(6):2219-26. PubMed ID: 9165004
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Rac activation as a mechanism for negative regulation of actin cytoskeletal reorganization and cell motility by cAMP.
Nagasawa SY; Takuwa N; Sugimoto N; Mabuchi H; Takuwa Y
Biochem J; 2005 Feb; 385(Pt 3):737-44. PubMed ID: 15377280
[TBL] [Abstract][Full Text] [Related]
14. Modulation of lysophosphatidic acid-induced Cl- currents by protein kinases A and C in the Xenopus oocyte.
Kim MJ; Lee YS; Han JK
Biochem Pharmacol; 2000 Feb; 59(3):241-7. PubMed ID: 10609552
[TBL] [Abstract][Full Text] [Related]
15. The biphasic induction of p21 and p27 in breast cancer cells by modulators of cAMP is posttranscriptionally regulated and independent of the PKA pathway.
Rao S; Gray-Bablin J; Herliczek TW; Keyomarsi K
Exp Cell Res; 1999 Oct; 252(1):211-23. PubMed ID: 10502413
[TBL] [Abstract][Full Text] [Related]
16. cAMP Dose-dependently prevents palmitate-induced apoptosis by both protein kinase A- and cAMP-guanine nucleotide exchange factor-dependent pathways in beta-cells.
Kwon G; Pappan KL; Marshall CA; Schaffer JE; McDaniel ML
J Biol Chem; 2004 Mar; 279(10):8938-45. PubMed ID: 14688288
[TBL] [Abstract][Full Text] [Related]
17. Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway.
Fukuhara S; Sakurai A; Sano H; Yamagishi A; Somekawa S; Takakura N; Saito Y; Kangawa K; Mochizuki N
Mol Cell Biol; 2005 Jan; 25(1):136-46. PubMed ID: 15601837
[TBL] [Abstract][Full Text] [Related]
18. Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: a comparison of the effects of cyclic adenosine 3',5'-monophosphate, estradiol, insulin-like growth factor-I, and serum factors.
Cho H; Aronica SM; Katzenellenbogen BS
Endocrinology; 1994 Feb; 134(2):658-64. PubMed ID: 7507831
[TBL] [Abstract][Full Text] [Related]
19. Elevation of cyclic AMP in Jurkat T-cells provokes distinct transcriptional responses through the protein kinase A (PKA) and exchange protein activated by cyclic AMP (EPAC) pathways.
Fuld S; Borland G; Yarwood SJ
Exp Cell Res; 2005 Sep; 309(1):161-73. PubMed ID: 15963501
[TBL] [Abstract][Full Text] [Related]
20. Role of the exchange protein directly activated by cyclic adenosine 5'-monophosphate (Epac) pathway in regulating proglucagon gene expression in intestinal endocrine L cells.
Lotfi S; Li Z; Sun J; Zuo Y; Lam PP; Kang Y; Rahimi M; Islam D; Wang P; Gaisano HY; Jin T
Endocrinology; 2006 Aug; 147(8):3727-36. PubMed ID: 16644915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
